EMPLICITI

Facts of EMPLICITI

• Medicine Name: EMPLICITI
• Medicine Name: (elotuzumab)
• Company Name: BMS

What is EMPLICITI ?

EMPLICITI is a SLAMF7-directed immunostimulatory antibody indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received one to three prior therapies.
EMPLICITI is indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received one to three prior therapies.